7 / 8
Page 18
Notes:
allied
academies
Journal of Diabetology | Volume 3
Annual Summit on
Diabetes, Obesity & Heart
Diabetes, Endocrinology and Metabolic Syndrome
International Conference on
Joint Event
&
March 07-08, 2019 | London, UK
A
literature search from 2011 to date was conducted. An
impact of diabetes on the peripheral circulation has been of
a late stage occurrence. However, it is recognized as a significant
complication due to further progression of the disease leading to
an irreversible consequence e.g. amputation of the lower limb.
As a treatment in earlier research Hyperbaric oxygen therapy
was considered following a failure of antimicrobial treatment
of foot ulcers. Later, a compromised circulation was identified
as being responsible for the resistance in healing ulcers and
subsequent antibacterial resistance. Finally, in literature,
inconsistency in the diagnostic methods for peripheral arterial
disease has been recognized. In our research, observations of
clinical presentation e.g. the feeling of cold feet as a persistent
occurrence, numbness, discoloration (pale green, blue) have
been a common finding. Our research utilizing “Perivasc/
Diab” (our own creation), since 2015, has been based on early
identification of vascular compromise among poorly controlled
diabetics. A topical application twice a day for 30 to 90 days,
in a population of 30 patients has yielded reversal of vascular
compromise and restoration to normally functioning limbs.
In Perivasc, active ingredients were responsible for a vasodilator
effect. A continued application twice a day and by eliminating
predisposing factors e.g. smoking and glycaemic control were
essential to see optimum resolution. The active ingredients in
the pilot study were also recognized as effective treatment
measures in urological and cardio-vascular diseases. The study
will be continued for a further review of these supplemental
benefits. Through the course of the entire study no side effects
have been observed.
Speaker Biography
Vinod Chandra Tawar has earned BSc Hons. and BSc Tech. Pharmaceuticals fromUniversity
of Bombay. He was offered a teaching assistantship at the School of Pharmacy, University
of Manitoba, Canada, where he achieved a Post-graduate (MSc) degree in Pharmacology
followed by working as a Toxicologist at a University Hospital in Winnipeg for a duration of
10 years. In due course, he developed a Toxicology laboratory for patient management and
Forensic purposes. This later became a reference laboratory for the Province of Manitoba.
In 1981, he decided to study Medicine and graduated Medicine in 1985. Subsequently,
he joined Douglas Hospital Research Centre at McGill University as a Psychiatry Research
Consultant with participation in projects on depression, Alzheimer’s disease, alcoholism
and schizophrenia. Currently he is working in King George Medical Clinic, Canada.
e:
vinodtawar1943@gmail.comVinod Chandra Tawar
King George Medical Clinic, Canada
Diabetic foot disease an innovation in treatment